Open AccessDetection of Atrial Fibrillation Among Patients With Stroke Due to Large or Small Vessel Disease: A Meta‐Analysis
Author(s) -
Demeestere Jelle,
Fieuws Steffen,
Lansberg Maarten G.,
Lemmens Robin
Publication year - 2016
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004151
Subject(s) - medicine , stroke (engine) , atrial fibrillation , cardiology , etiology , population , meta analysis , cardiac monitoring , mechanical engineering , environmental health , engineering
Background Recent trials have demonstrated that extended cardiac monitoring increases the yield of paroxysmal atrial fibrillation ( AF ) detection in patients with cryptogenic stroke. The utility of extended cardiac monitoring is uncertain among patients with stroke caused by small and large vessel disease. We conducted a meta‐analysis to estimate the yield of AF detection in this population. Methods and Results We searched PubMed, Cochrane, and SCOPUS databases for studies on AF detection in stroke patients and excluded studies restricted to patients with cryptogenic stroke or transient ischemic attack. We abstracted AF detection rates for 3 populations grouped by stroke etiology: large vessel stroke, small vessel stroke, and stroke of undefined etiology (a mixture of cryptogenic, small vessel, large vessel, and other stroke etiologies). Our search yielded 30 studies (n=5687). AF detection rates were similar in patients with large vessel (2.2%, 95% CI 0.3–5.5; n=830) and small vessel stroke (2.4%, 95% CI 0.4–6.1; n=520). No studies had a monitoring duration longer than 7 days. The yield of AF detection in the undefined stroke population was higher (9.2%; 95% CI 7.1–11.5) compared to small vessel stroke ( P =0.02) and large vessel stroke ( P =0.02) populations. Conclusions AF detection rate is similar in patients with small and large vessel strokes (2.2–2.4%). Because no studies reported on extended monitoring (>7 days) in these stroke populations, we could not estimate the yield of AF detection with long‐term cardiac monitoring. Randomized controlled trials are needed to examine the utility of AF detection with long‐term cardiac monitoring (>7 days) in this patient population.